-
1 Comment
China Medical System Holdings Limited is currently in a long term uptrend where the price is trading 40.1% above its 200 day moving average.
From a valuation standpoint, the stock is 95.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
China Medical System Holdings Limited's total revenue rose by 23.4% to $4B since the same quarter in the previous year.
Its net income has increased by 58.2% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 141.2% to $616M since the same quarter in the previous year.
Based on the above factors, China Medical System Holdings Limited gets an overall score of 5/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG211081248 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 11.93 |
|---|---|
| Target Price | 10.6182 |
| Beta | 0.91 |
| Market Cap | 20B |
| Dividend Yield | 3.5% |
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat decompensated heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis. The company also offers Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-to-severe plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macular degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis. In addition, it provides Aethoxysklerol for sclerotherapy of different varicose veins; Heling Soothing product for skin soothing; Vmonalisa for mid to deep dermal implantation; EyeOP1 to treat glaucoma; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; MOVICOL for treating chronic constipation and faecal impaction; and MeteoSpasmyl to treat gastrointestinal flatulence and pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0867.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
